• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Del Global reconciles with shareholders

Article

Trying to settle a lawsuit initiated in November after accounting irregularities were uncovered, Del Global has reached a tentative deal with shareholders. Under the agreement, Del will contribute $2 million in a subordinated note due in five years with

Trying to settle a lawsuit initiated in November after accounting irregularities were uncovered, Del Global has reached a tentative deal with shareholders. Under the agreement, Del will contribute $2 million in a subordinated note due in five years with interest at 6% per annum, 2.5 million shares of Del stock, and warrants to purchase one million shares exercisable at $2.00 per share, expiring in six years. The plaintiffs will also receive a $2 million cash payment to which Del will not contribute. The courts must yet approve the deal. In a separate action, Samuel E. Park has been appointed president and CEO of Del. Park has acted in this capacity since February.

Related Videos
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.